Country: Canada
Language: English
Source: Health Canada
ESTRADIOL VALERATE
PHARMASCIENCE INC
G03CA03
ESTRADIOL
10MG
LIQUID
ESTRADIOL VALERATE 10MG
INTRAMUSCULAR
10ML
Prescription
ESTROGENS
Active ingredient group (AIG) number: 0106456001; AHFS:
CANCELLED POST MARKET
2016-10-28
PRODUCT MONOGRAPH PR PMS-ESTRADIOL VALERATE INJECTION Estradiol Valerate 10 mg/mL ESTROGEN PHARMASCIENCE INC. DATE OF REVISION: 6111 Royalmount Avenue, Suite 100 JUNE 30, 2009 Montreal, Quebec H4P 2T4 CONTROL NUMBER: 120632 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION……………………………... 3 SUMMARY PRODUCT INFORMATION……………………………………….3 INDICATIONS AND CLINICAL USE…………………………………………...3 CONTRAINDICATIONS…………………………………………………………4 WARNINGS AND PRECAUTIONS…………………………………….……….5 ADVERSE REACTIONS………………………………………………………...13 DRUG INTERACTIONS………………………………………………………...15 DOSAGE AND ADMINISTRATION…………………………………………...17 OVERDOSAGE………………………………………………………………….19 ACTION AND CLINICAL PHARMACOLOGY……………………………….19 STORAGE AND STABILITY…………………………………………………...22 DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..22 PART II: SCIENTIFIC INFORMATION……………………………………………. 23 PHARMACEUTICAL INFORMATION………………………………………...23 CLINICAL TRIALS……………………………………………………………...24 DETAILED PHARMACOLOGY………………………………………………..24 REFERENCES…………………………………………………………………...25 PART III: CONSUMER INFORMATION…………………………………………………… 27 2 PRODUCT MONOGRAPH PR PMS- ESTRADIOL VALERATE INJECTION (Estradiol Valerate) 10 mg/mL PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION ROUTE OF ADMINISTRATION DOSAGE FORM / STRENGTH CLINICALLY RELEVANT NONMEDICINAL INGREDIENTS Intramuscular Injection / 10 mg/mL Sesame Oil _For a complete listing see Dosa Read the complete document